000 01520 a2200325 4500
005 20250517021556.0
264 0 _c20151026
008 201510s 0 0 eng d
022 _a1824-4785
040 _aNLM
_beng
_cNLM
100 1 _aGuerard, F
245 0 0 _aWhich radionuclide, carrier molecule and clinical indication for alpha-immunotherapy?
_h[electronic resource]
260 _bThe quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...
_cJun 2015
300 _a161-7 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAlpha Particles
_xtherapeutic use
650 0 4 _aDrug Carriers
_xchemical synthesis
650 0 4 _aEvidence-Based Medicine
650 0 4 _aHumans
650 0 4 _aImmunotherapy
_xmethods
650 0 4 _aIsotope Labeling
_xmethods
650 0 4 _aNeoplasms
_xradiotherapy
650 0 4 _aRadioisotopes
_xtherapeutic use
700 1 _aBarbet, J
700 1 _aChatal, J F
700 1 _aKraeber-Bodere, F
700 1 _aCherel, M
700 1 _aHaddad, F
773 0 _tThe quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...
_gvol. 59
_gno. 2
_gp. 161-7
999 _c24689962
_d24689962